We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

1 hedge funds and large institutions have $5 invested in TRACON Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

94% less capital invested

Capital invested by funds: $80 → $5 (-$75)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GPFA
1
Game Plan Financial Advisors
Ohio
$5 – – –

TCON Hedge Fund Activity: Q3 2024 in Review

1 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals, Inc. Common Stock (TCON) for Q3 2024, worth a combined $5 — down 94% from $80 a quarter earlier.

Fund positioning in TCON was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held TRACON Pharmaceuticals, Inc. Common Stock (TCON) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $5 of TRACON Pharmaceuticals, Inc. Common Stock stock for Q3 2024, down 94% quarter-over-quarter.
  • 0 funds opened new TRACON Pharmaceuticals, Inc. Common Stock positions in Q3 2024 and 0 closed out.

Based on aggregated 13F filings for Q3 2024.